More info…
Omeros Corporation today announced that the National Institute on Drug Abuse is providing support for the Company’s Addiction program. NIDA will fund substantially all of the costs of a Phase 2 clinical study to be conducted by New York State Psychiatric Institute researchers.
Omeros Announces National Institute on Drug Abuse’s Support for Phase 2 Clinical Study in Addiction Program (PR Newswire via Yahoo! Finance)
January 31, 2010 By Leave a Comment
